Comparing The Effect Of Suboccipital Myofascial Release And Remote Release By Dynamic Cupping On Cervicogenic Headache
Trial Snapshot
- Phase
- Phase 2/3
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 56
- Locations
- 1
- Primary Endpoint
- Numeric Pain Rating Scale (NPRS)
Study Overview
Brief Summary
This study investigates the comparative and combined effects of Myofascial Release (MFR) and Cupping Therapy on adults suffering from neck-related headaches, often associated with cervicogenic or tension-type origins. The research aims to assess improvements in headache intensity, frequency, cervical range of motion, and overall quality of life. Participants were divided into groups receiving MFR, cupping therapy, or a combination of both. Results indicate that both therapies significantly reduce headache symptoms, with the combined approach yielding superior outcomes in pain relief and functional improvement. These findings support the integration of manual therapies in the conservative management of neck-related headaches.
Study Design
- Study Type
- Interventional
- Allocation
- Computer generated randomization
- Masking
- Participant Blinded
Eligibility Criteria
- Ages
- 20.00 Year(s) to 30.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Individuals with cervicogenic headache of 20 to 30 years of age both male and female, Individuals with Cervicogenic Headache as diagnosed by International Classification of Headache (ICH) and Individuals with unilateral head pain in occipital and upper posterior neck region.
Exclusion Criteria
- •Individuals with cervicogenic headache of 20 to 30 years of age both male and female, Individuals with Cervicogenic Headache as diagnosed by International Classification of Headache (ICH) and Individuals with unilateral head pain in occipital and upper posterior neck region.
Outcomes
Primary Outcomes
Numeric Pain Rating Scale (NPRS)
Time Frame: Baseline, 4th week
Neck disability index
Time Frame: Baseline, 4th week
Headache impact test-6
Time Frame: Baseline, 4th week
Inclinometer
Time Frame: Baseline, 4th week
Secondary Outcomes
No secondary outcomes reported